Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Evofem Biosciences Inc (EVFM)  
$1.00 0.00 (0.00%) as of 4:30 Thu 6/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 35,380,000
Market Cap: 35.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.0152 - $1.25
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Evofem Biosciences is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health, including woman-controlled contraception and protection from certain sexually transmitted infections. Co.'s commercial product, Phexxi, is the U.S. Food and Drug Administration (FDA)-approved, hormone-free, woman-controlled, prescription contraceptive gel for women. Co. is evaluating Phexxi for two potential new indications: the prevention of chlamydia and the prevention of gonorrhea in women. The FDA has designated Phexxi, using the investigational name EVO100, as a Qualified Infectious Disease Product.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 141,000
Total Buy Value $0 $0 $0 $49,703
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 114 114 114
Total Sell Value $0 $10 $10 $10
Total People Sold 0 2 2 2
Total Sell Transactions 0 2 2 2
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 194
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Zhang Yan CFO   •       –      –    2024-01-12 4 S $0.04 $4 D/D (104) 0     -
   Kamdar Kim P. Director   –       •      –    2023-12-21 4 S $0.62 $6 D/D (10) 0     -
   Zhang Yan Chief Financial OfficerOfficer   •       –      –    2023-04-13 3 IO $0.00 $0 D/D 0 13,000 4,826%     
   Pelletier Saundra L Chief Executive Officer   •       •      –    2022-12-31 4 D $0.00 $0 D/D (50,000) 186,722     -
   Atkinson Katherine Cocca Chief Commercial OfficerOffice   •       –      –    2022-05-31 3 IO $0.00 $0 D/D 0 16,667 -52%     
   Pelletier Saundra L Chief Executive Officer   •       •      –    2022-05-27 4 B $0.35 $49,703 D/D 141,000 236,722 2.81 -54%     
   File Justin J. Chief Financial Officer   •       –      –    2022-02-18 4 A $0.00 $0 D/D 450,000 810,982     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2022-02-18 4 A $0.00 $0 D/D 750,000 1,435,837     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2022-02-18 4 A $0.00 $0 D/D 300,000 516,422     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2021-12-31 4 D $0.00 $0 D/D (120,000) 216,422     -
   File Justin J. Chief Financial Officer   •       –      –    2021-12-31 4 D $0.00 $0 D/D (120,000) 360,982     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2021-12-31 4 D $0.00 $0 D/D (300,000) 685,837     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2021-12-20 4 B $0.38 $50,625 D/D 135,000 985,837 2.81     -
   File Justin J. Chief Financial Officer   •       –      –    2021-12-20 4 B $0.37 $15,020 D/D 40,594 480,982 2.74     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2021-12-20 4 B $0.39 $9,725 D/D 25,000 336,422 2.74     -
   Barrans Russell Chief Commercial Officer   •       –      –    2021-07-08 4 D $0.98 $19,498 D/D (19,998) 448,554     -
   Kamdar Kim P. Director   –       •      –    2021-06-18 4 B $1.17 $11,650 D/D 10,000 19,287 2.39     -
   Obrien Anthony Stephen Director   –       •      –    2021-06-14 4 B $1.31 $10,663 D/D 8,140 8,140 2.39     -
   Rarick Lisa Dale Director   –       •      –    2021-06-11 4 B $1.20 $5,990 D/D 5,000 10,250 2.39     -
   Barrans Russell Chief Commercial Officer   •       –      –    2021-06-11 4 B $1.14 $20,725 D/D 18,180 468,552 2.74     -
   File Justin J. Chief Financial Officer   •       –      –    2021-06-10 4 B $1.03 $25,235 D/D 24,500 440,388 2.74     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2021-06-10 4 B $1.03 $10,250 D/D 10,000 311,422 2.74     -
   Pelletier Saundra L Chief Executive Officer   •       •      –    2021-06-10 4 B $1.03 $51,500 D/D 50,000 850,837 2.81     -
   Fitzpatrick Alexander A General Counsel and Secretary   •       –      –    2021-05-20 4 D $0.86 $36,223 D/D (42,120) 301,422     -
   Barrans Russell Chief Commercial Officer   •       –      –    2021-05-20 4 D $0.86 $27,073 D/D (31,480) 450,372     -
  194 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us